News - Brightlands Venture Partners

Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells® treatment for Traumatic Spinal Cord Injury

March 29, 2022

Mane Biotech raises € 1.7 million to further develop its regenerative medicine technology to combat hair loss

January 18, 2022

PectCof raises € 2 million for its innovative coffee pulp-based food ingredients

January 12, 2022

Verdify raises €1.3 million to scale its Swapmeals® platform for personalised recipes

December 13, 2021

Matisse Pharmaceuticals receives approval from the Dutch Health Authorities to initiate a Phase I study with lead compound M6229

November 22, 2021

Dutch stem cell biotech Neuroplast secures € 10 million in Series B funding

November 17, 2021

Vertoro raises funding to scale up its Goldilocks® liquid lignin technology

October 14, 2021

Qorium raises € 2.6 mln to further develop its truly sustainable cultivated leather technology

July 08, 2021

Groundbreaking treatment for type II endoleaks proves very successful

June 07, 2021

PL BioScience raises € 3.7 mln from Born2Grow, Brightlands Venture Partners, TechVision Fund I and more

May 25, 2021

Ioniqa attracts € 10 million funding

May 18, 2021

Black Bear Carbon raises € 7.5 million in a first closing for its new flagship plant

May 17, 2021

More information

If you have any questions or want to know more about us
Contact us